Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology

Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer

(2015) Ewa Ruel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: A meta-analysis

(2014) Jian Tu et al.   RADIOTHERAPY AND ONCOLOGY

Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients

(2013) Maria Grazia Castagna et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Approach to Follow-Up of the Patient With Differentiated Thyroid Cancer and Positive Anti-Thyroglobulin Antibodies

(2013) Matthew D. Ringel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up

(2013) Eleonora Molinaro et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

(2012) Martin Schlumberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

(2012) Ujjal Mallick et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incremental Diagnostic Value of SPECT/CT with131I Scintigraphy after Radioiodine Therapy in Patients with Well-differentiated Thyroid Carcinoma

(2012) Yasuhiro Maruoka et al.   RADIOLOGY

A Low Postoperative Nonstimulated Serum Thyroglobulin Level Does Not Exclude the Presence of Radioactive Iodine Avid Metastatic Foci in Intermediate-Risk Differentiated Thyroid Cancer Patients

(2012) Eyal Robenshtok et al.   THYROID

124I Positron Emission Tomography Versus 131I Planar Imaging in the Identification of Residual Thyroid Tissue and/or Metastasis in Patients Who Have Well-Differentiated Thyroid Cancer

(2010) Douglas Van Nostrand et al.   THYROID

Value of Postoperative Thyroglobulin and Ultrasonography for the Indication of Ablation and 131I Activity in Patients with Thyroid Cancer and Low Risk of Recurrence

(2010) Pedro Weslley Rosario et al.   THYROID

Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal

(2009) Anna Frigo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study

(2008) D. Taïeb et al.   CLINICAL ENDOCRINOLOGY

Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients

(2008) M Chianelli et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen

(2008) I. Borget et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy

(2008) Michael Lassmann et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal

(2008) R. M. Tuttle et al.   JOURNAL OF NUCLEAR MEDICINE

Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study

(2008) Hanna O. Mäenpää et al.   PLoS One